Viewpoint Molecular Targeting, Inc.
Biotechnology company · Coralville, Iowa, United States
Viewpoint Molecular Targeting, Inc. is a biotechnology company headquartered in Coralville, Iowa, United States. It has received 11 US government small-business research awards (SBIR/STTR) from health agencies, $13 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $14 million sold in a notice filed in 2021.
Viewpoint Molecular Targeting at a glance
What does Viewpoint Molecular Targeting do?
US government research funding
11 SBIR/STTR small-business research awards from US health agencies, $13.3 million in total (2015 to 2024). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $14.3 million sold (2021).
Frequently asked questions about Viewpoint Molecular Targeting
Where is Viewpoint Molecular Targeting headquartered?
Viewpoint Molecular Targeting, Inc. is headquartered in Coralville, Iowa, United States.
What does Viewpoint Molecular Targeting do?
Viewpoint Molecular Targeting, Inc. is a biotechnology company.
Similar companies
- Iowa Adaptive Technologies, Inc.Coralville, Iowa, United States
- Cellular Engineering Technologies, Inc.Coralville, Iowa, United States
- Emmyon, Inc.Coralville, Iowa, United States
- Nanomedtrix LLCCoralville, Iowa, United States
- Infondrian LLCCoralville, Iowa, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences